Рябов Вячеслав Валерьевич


Сортировать:

EPIVER ClinicalTrials.gov

Статус: Completed
Фаза: N/A
Начало: 30 декабря 2020 г.
Окончание: 31 января 2024 г.
Описание: The trial aims to estimate the efficacy and safety of the intracoronary administration of adrenalin, verapamil, as well as their combination compared to standard treatment in patients with STEMI and refractory coronary no-reflow despite conventional treatment during percutaneous coronary intervention (PPCI)
смотреть на ClinicalTrials.gov

SNP_1 ClinicalTrials.gov

Статус: Completed
Фаза:  не указано
Начало: 15 марта 2019 г.
Окончание: 30 сентября 2020 г.
Описание: The purpose of this study is to explore the serum levels of pro- and anti-inflammatory biomarkers and angiogenic growth factors and SNP polymorphisms of the promoter regions of their genes as well as to determine their role in the development of adverse cardiac remodeling in patients with acute ST-segment elevation myocardial infarction.
смотреть на ClinicalTrials.gov

MINOCA ClinicalTrials.gov

Статус: Completed
Фаза: N/A
Начало: 28 мая 2018 г.
Окончание: 30 сентября 2020 г.
Описание: The purpose of this study is to improve the differential diagnosis and clinical outcomes of acute coronary syndrome with non-obstructive coronary arteries, to investigate the relationship between the structural and functional state of the heart and the clinical course of the disease.
смотреть на ClinicalTrials.gov

FABP ClinicalTrials.gov

Статус: Completed
Фаза: N/A
Начало: 2 мая 2017 г.
Окончание: 1 октября 2018 г.
Описание: Predictable values of the 1-hour algorithm for estimating the concentration of troponin using highly sensitive reagents are 98-100% for excluding myocardial infarction (MI) and 75-80% for identifying this pathology. Such algorithms are developed for the rapid confirmation or exclusion of myocardial infarction without ST-segment elevation and, when combined with clinical data and electrocardiogram, are used to assess the risk of adverse course of disease and to contribute to decision making about expediency of stay in the intensive therapy unit and early discharge. In mid-1980s, a new marker of myocardial damage was proposed, namely: fatty-acid-binding protein (FABP). However, the diagnostic value of FABP cannot be interpreted unambiguously because of insufficient number of studies determining the sensitivity and specificity of the test in various manifestations of acute coronary syndrome (ACS). Available literature presents a wide range of reference values of FABP for MI diagnosis. Reference value ranges are proposed by manufacturers of diagnostic kits based on previous studies. In addition, there is no information about the FABP changes during the first three hours of the disease, as well as there are no data on diagnostic value of changes in this indicator ("∆") in patients with ACS without ST-segment elevation. These considerations provide rationale and support novelty of the planned pilot study.
смотреть на ClinicalTrials.gov

1801 ClinicalTrials.gov

Статус: Unknown status
Фаза: N/A
Начало: 1 января 2016 г.
Окончание: 1 октября 2018 г.
Описание: The purpose of the study is to investigate the clinical and morphological characteristics of chronic subclinical inflammation in the myocardium in patients with decompensated heart failure with ischemic systolic dysfunction.
смотреть на ClinicalTrials.gov

1801 ClinicalTrials.gov

Статус: Unknown status
Фаза: N/A
Начало: 1 января 2016 г.
Окончание: 1 октября 2018 г.
Описание: The purpose of the study is to investigate the clinical and morphological characteristics of chronic subclinical inflammation in the myocardium in patients with decompensated heart failure with ischemic systolic dysfunction.
смотреть на ClinicalTrials.gov

1801 ClinicalTrials.gov

Статус: Unknown status
Фаза: N/A
Начало: 1 января 2016 г.
Окончание: 1 октября 2018 г.
Описание: The purpose of the study is to investigate the clinical and morphological characteristics of chronic subclinical inflammation in the myocardium in patients with decompensated heart failure with ischemic systolic dysfunction.
смотреть на ClinicalTrials.gov

2411 ClinicalTrials.gov

Статус: Unknown status
Фаза: N/A
Начало: 1 октября 2015 г.
Окончание: 1 сентября 2018 г.
Описание: The purpose of the study is to assess short and long term outcomes of acute coronary syndrome in patients with non obstructive coronary atherosclerosis, to optimize the algorithm for diagnosis and to evaluate its effectiveness
смотреть на ClinicalTrials.gov

2411 ClinicalTrials.gov

Статус: Unknown status
Фаза: N/A
Начало: 1 октября 2015 г.
Окончание: 1 сентября 2018 г.
Описание: The purpose of the study is to assess short and long term outcomes of acute coronary syndrome in patients with non obstructive coronary atherosclerosis, to optimize the algorithm for diagnosis and to evaluate its effectiveness
смотреть на ClinicalTrials.gov

1202 ClinicalTrials.gov

Статус: Unknown status
Фаза: Phase 2/Phase 3
Начало: 1 февраля 2014 г.
Окончание: 1 июня 2017 г.
Описание: The purpose of the study is to investigate the changes of myocardial biomechanics and efficacy of doxycycline in patients with primary anterior STEMI.
смотреть на ClinicalTrials.gov